New Phase 2 Patient Data Presented at ASCO Strengthen the Evidence for AntiTumor Activity of VB111 in Recurrent GBM

Press/Media: Press / Media

PeriodJun 5 2017

Media coverage

1

Media coverage

  • TitleNew Phase 2 Patient Data Presented at ASCO Strengthen the Evidence for AntiTumor Activity of VB111 in Recurrent GBM
    Media name/outletBioPortfolio
    CountryUnited Kingdom
    Date6/5/17
    PersonsAndrew Brenner